RRC ID 77349
Author Daniels DE, Ferrer-Vicens I, Hawksworth J, Andrienko TN, Finnie EM, Bretherton NS, Ferguson DCJ, Oliveira ASF, Szeto JA, Wilson MC, Brewin JN, Frayne J.
Title Human cellular model systems of β-thalassemia enable in-depth analysis of disease phenotype.
Journal Nat Commun
Abstract β-thalassemia is a prevalent genetic disorder causing severe anemia due to defective erythropoiesis, with few treatment options. Studying the underlying molecular defects is impeded by paucity of suitable patient material. In this study we create human disease cellular model systems for β-thalassemia by gene editing the erythroid line BEL-A, which accurately recapitulate the phenotype of patient erythroid cells. We also develop a high throughput compatible fluorometric-based assay for evaluating severity of disease phenotype and utilize the assay to demonstrate that the lines respond appropriately to verified reagents. We next use the lines to perform extensive analysis of the altered molecular mechanisms in β-thalassemia erythroid cells, revealing upregulation of a wide range of biological pathways and processes along with potential novel targets for therapeutic investigation. Overall, the lines provide a sustainable supply of disease cells as research tools for identifying therapeutic targets and as screening platforms for new drugs and reagents.
Volume 14(1)
Pages 6260
Published 2023-10-6
DOI 10.1038/s41467-023-41961-9
PII 10.1038/s41467-023-41961-9
PMID 37803026
PMC PMC10558456
MeSH Erythroid Cells Erythropoiesis / genetics Humans Phenotype beta-Thalassemia* / genetics beta-Thalassemia* / therapy
IF 12.121
Resource
Human and Animal Cells HUDEP-2(RCB4557)